Roche Diagnostics GmbH
Clinical trials sponsored by Roche Diagnostics GmbH, explained in plain language.
Now part of
Roche Holding AG
RHHBY
OTC
Diagnostics division of Roche, providing in-vitro diagnostic products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Needle-Free hope: new blood test may detect liver scarring without painful biopsy Results expected Dec 2026 (estimated)